APO TRA 650 (Tranexamic acid 650 mg)
Pill imprint APO TRA 650 has been identified as Tranexamic acid 650 mg.
Tranexamic acid is used in the treatment of menorrhagia; bleeding disorder; melasma; factor ix deficiency; hemophilia a (and more), and belongs to the drug class miscellaneous coagulation modifiers. There is no proven risk in humans during pregnancy. Tranexamic acid 650 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO TRA 650
- Strength:
- 650 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous coagulation modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
More about tranexamic acid
Consumer resources
- Tranexamic acid
- Tranexamic acid tablet
- Tranexamic acid (Advanced Reading)
- Tranexamic acid Intravenous (Advanced Reading)
- Other brands: Lysteda, Cyklokapron
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
